Home/Filings/4/0001144204-12-025757
4//SEC Filing

Egbaria Kamel 4

Accession 0001144204-12-025757

CIK 0000887497other

Filed

May 2, 8:00 PM ET

Accepted

May 3, 12:38 PM ET

Size

5.7 KB

Accession

0001144204-12-025757

Insider Transaction Report

Form 4
Period: 2012-04-26
Egbaria Kamel
Chief Scientific Officer, EVP
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-04-26+40,00040,000 total
    Exercise: $33.54From: 2013-04-26Exp: 2022-04-26Common Stock (40,000 underlying)
Footnotes (3)
  • [F1]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan.
  • [F2]The Option becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
  • [F3]The filer is also the holder of additional options to acquire an aggregate of 80,000 shares of Hi-Tech Pharmacal Co., Inc. common stock, which options were granted in 2010 and 2011.

Issuer

HI TECH PHARMACAL CO INC

CIK 0000887497

Entity typeother

Related Parties

1
  • filerCIK 0001490469

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 12:38 PM ET
Size
5.7 KB